etoposide has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gruellich, C; Hasskarl, J; Schroettner, P; Waller, CF | 1 |
| Jensen, DM; Pedersen, RS | 1 |
2 other study(ies) available for etoposide and Bright Disease
| Article | Year |
|---|---|
Achievement of a continuous complete remission in a kidney transplant patient with advanced donor-derived small cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cadaver; Carboplatin; Carcinoma, Small Cell; Etoposide; Glomerulonephritis; Humans; Immunosuppressive Agents; Immunotherapy; Kidney Transplantation; Male; Middle Aged; Neoplasm Metastasis; Tissue Donors | 2010 |
Treatment of ANCA-positive, pauci-immune extracapillary glomerulonephritis with etoposide.
Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Azathioprine; Etoposide; Glomerulonephritis; Humans; Male; Middle Aged | 1995 |